A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel ...

AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on February 11, 2025, announced that its independently developed mRNA shingles vaccine has been submitted for ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually. In a ...

At present, there are no licensed vaccines to prevent melioidosis, an important emerging infectious disease caused by B. pseudomallei. Research in the Burtnick lab is currently focused on the ...

In our opinion, the five most important issues facing RSV F protein subunit-based vaccines in the next 5–10 years are the following: Determining whether RSV F protein subunit vaccines will be ...

The growth of the vaccine technologies market is driven by rise in prevalence of infectious diseases, growing trend towards preventive healthcare, and government immunization programs and initiatives.

Currently, there are two types of COVID-19 vaccines for use in the United States: mRNA vaccines and protein subunit vaccines. All COVID-19 vaccines provide protection from the virus that causes ...

viral vector vaccines; (iii) protein subunit vaccines, (iv) mRNA vaccines. 5 Medical efficacy refers to a vaccine’s ability to produce the desired immune response under controlled conditions ...

F protein-subunit based vaccines, adjuvants & potency Both prefusion and postfusion F protein vaccines are being tested in clinical trials. Previous studies showed that alum had a modest effect on ...